Under Atmanirbhar Bharat 3.0 Mission COVID Suraksha was announced by the Government of India, to accelerate the development and production of Indigenous COVID Vaccines. This is being implemented by Department of Biotechnology Govt. of India.
3 public sectors companies are also being supported to increase the capacity of vaccine production.
Haffkine Biopharmaceutical Corporation Ltd, Mumbai –a State PSE under State Govt of Maharashtra. Financial support as grant from GoI to the tune of appx Rs 65 Cr will be provided for this facility to be made ready for manufacturing. The Haffkine Biopharmaceuticals Ltd had asked for around 12 months to complete this task. However, the Central government has asked them to expedite and complete the task urgently within 6 months. The facility will have a capacity of 20 million dozes per month, once functional.
Indian Immunologicals Limited (IIL), Hyderabad –A facility under National Dairy Development Board and Bharat Immunologicals and Biologicals Limited (BIBCOL) , Bulandshahr a CPSE under Department of Biotechnology ,Govt of India will also be supported to prepare their facility to provide 10-15 million dozes per month by Aug – Sep 2021.
